Mivazerol

Drug Profile

Mivazerol

Alternative Names: UCB 22073

Latest Information Update: 26 Nov 1999

Price : $50

At a glance

  • Originator UCB
  • Class Anti-ischaemics
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Ischaemic heart disorders; Perioperative ischaemia; Tachycardia

Most Recent Events

  • 26 Nov 1999 A study has been added to the Ischaemic Heart Disease pharmacodynamics section
  • 26 Nov 1999 A study has been added to the Ischaemic Heart Disease therapeutic trials section
  • 31 Dec 1998 Discontinued-II for Ischaemic heart disorders in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top